Vext Announces Voting Results of Annual General Meeting
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, announced the voting results from its annual general meeting held on December 13, 2024, in Vancouver. Shareholders demonstrated strong support for all matters presented in the management information circular, with each resolution passing with over 98% approval. The voting represented 73.45% of the total issued and outstanding shares of the company.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un operatore statunitense nel settore della cannabis con operazioni verticali in Arizona e Ohio, ha annunciato i risultati delle votazioni della sua assemblea generale annuale tenutasi il 13 dicembre 2024 a Vancouver. Gli azionisti hanno dimostrato un forte supporto per tutte le questioni presentate nel circolare informativa della direzione, con ogni risoluzione approvata con oltre 98% di approvazione. Il voto ha rappresentato 73,45% del totale delle azioni emesse e in circolazione della società.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un operador de cannabis con sede en EE. UU. con operaciones verticales en Arizona y Ohio, anunció los resultados de la votación de su reunión general anual celebrada el 13 de diciembre de 2024 en Vancouver. Los accionistas demostraron un fuerte apoyo para todos los asuntos presentados en el documento informativo de la dirección, con cada resolución aprobada con más de 98% de aprobación. La votación representó el 73.45% del total de acciones emitidas y en circulación de la empresa.
Vext Science (CSE: VEXT, OTCQX: VEXTF)는 미국에 본사를 둔 대마초 운영업체로, 아리조나와 오하이오에 수직 운영을 하고 있으며, 2024년 12월 13일 밴쿠버에서 열린 연례 총회 결과를 발표했습니다. 주주들은 모든 안건에 대해 강력한 지지를 보였습니다, 각 결의안은 98% 이상의 찬성으로 통과되었습니다. 이번 투표는 회사의 총 발행 및 유통 주식의 73.45%를 차지했습니다.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un opérateur de cannabis basé aux États-Unis avec des opérations verticales en Arizona et Ohio, a annoncé les résultats du scrutin de son assemblée générale annuelle tenue le 13 décembre 2024 à Vancouver. Les actionnaires ont montré un fort soutien pour toutes les questions présentées dans le circular d'information de la direction, chaque résolution ayant été adoptée avec plus de 98% d'approbation. Le vote a représenté 73,45% du total des actions émises et en circulation de l'entreprise.
Vext Science (CSE: VEXT, OTCQX: VEXTF), ein in den USA ansässiger Betreiber von Cannabis mit vertikalen Operationen in Arizona und Ohio, hat die Abstimmungsergebnisse seiner Hauptversammlung, die am 13. Dezember 2024 in Vancouver stattfand, bekannt gegeben. Die Aktionäre zeigten starke Unterstützung für alle in dem Informationsrundschreiben der Geschäftsführung vorgestellten Angelegenheiten, wobei jede Resolution mit über 98% Zustimmung angenommen wurde. Die Abstimmung stellte 73,45% der insgesamt ausgegebenen und ausstehenden Aktien des Unternehmens dar.
- High shareholder participation rate of 73.45% indicates strong engagement
- Overwhelming shareholder support with over 98% approval on all resolutions
- None.
Vancouver, British Columbia--(Newsfile Corp. - December 13, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced final voting results from its annual general meeting of shareholders held on December 13, 2024 in Vancouver, British Columbia (the "Meeting").
The shareholders of the Company voted in favour of all matters included in the management information circular for the Meeting, demonstrating strong support for the matters brought before the Meeting, with each of the resolutions passing with over
For more details, visit Vext's investor website or contact the IR team at investors@vextscience.com.
About VEXT Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward-Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding future developments and the business and operations of Vext, including but not limited to the Company's transition to serve both the medical and adult-use markets in Ohio and the anticipated results therefrom, market projections of the cannabis industry in the jurisdictions in which the Company operates, and statements about the timing and completion of the Ohio Expansion Transaction, the acquisition of additional licenses and the opening of additional dispensaries in Ohio, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc.
[1]In total, 181,705,738 shares out of 247,390,811 shares the Company has issued and outstanding, were voted at the Meeting. The reference to shares means the Company's common shares and Class A shares reported on an as converted basis.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233732
FAQ
What was the voting approval percentage for Vext Science (VEXTF) resolutions at the December 2024 AGM?
What percentage of Vext Science (VEXTF) shares were represented in the December 2024 AGM voting?
Where does Vext Science (VEXTF) currently operate its cannabis business?
When and where was Vext Science's (VEXTF) 2024 Annual General Meeting held?
